Sequenom, Inc. (NASDAQ: SQNM) is focused on providing superior genetic analysis products designed to translate genomic science into advanced solutions for biomedical research, agricultural applications, molecular medicine and non-invasive prenatal diagnostics research, and possibly clinical utility. MassARRAY, the company’s high-performance DNA analysis platform, efficiently and precisely measures the amount of genetic target material as well as the variations within. For further information, visit the Company’s web site at www.sequenom.com.
- 18 years ago
QualityStocks
Sequenom, Inc. (NASDAQ: SQNM)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Hallmark Venture Group, Inc. (OTC: HLLK) Completes Drone Technology Acquisition, Transitions to Operating Business
Hallmark Venture Group (OTC: HLLK) announced the completion of a strategic transaction that transforms the company from…
-
QualityStocksNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Featured in BioMedWire Editorial on DNA Repair Cancer Therapies
This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising. Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) announced…
-
QualityStocksNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Releases RoadSight UGV Demonstration Video
Safe Pro Group (NASDAQ: SPAI), has released a demonstration video highlighting its new RoadSight capability,…